Literature DB >> 25448606

Role of miRNAs in endometrial cancer.

Shuangdi Li1, Jiarong Zhang2, Xiaoping Wan3.   

Abstract

Endometrial cancer (EC) is the most common gynecologic malignancy. MicroRNAs (miRNAs) were recently associated with carcinogenesis and progression of EC. In this review, we discuss recent advances and the emerging role of miRNAs in EC and their clinical implications, with special emphasis on the differences between deregulated miRNAs in type I and type II EC, as well as the impact of this dysregulation on EC initiation and progression.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25448606     DOI： 10.14670/HH-30.539

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN： 0213-3911            Impact factor:   2.303


  8 in total

1.  Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus.

Authors:  Ramesh Padmanabhan; Isabel R Hendry; Jennifer R Knapp; Bin Shuai; William J Hendry
Journal:  Cell Biol Toxicol       Date:  2017-03-06       Impact factor: 6.691

Review 2.  LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer.

Authors:  Arunoday Bhan; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-07-21

3.  Circ 003390/Eukaryotic translation initiation factor 4A3 promoted cell migration and proliferation in endometrial cancer via vascular endothelial growth factor signaling by miR-195-5p.

Authors:  Jing Ma; Xiwa Zhao; Li Shi
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Web-based tools for microRNAs involved in human cancer.

Authors:  Fermín Mar-Aguilar; Cristina Rodríguez-Padilla; Diana Reséndez-Pérez
Journal:  Oncol Lett       Date:  2016-04-18       Impact factor: 2.967

5.  Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Eric J Devor; Jeffrey Miecznikowski; Brandon M Schickling; Jesus Gonzalez-Bosquet; Heather A Lankes; Premal Thaker; Peter A Argenta; Michael L Pearl; Susan L Zweizig; Robert S Mannel; Amy Brown; Nilsa C Ramirez; Olga B Ioffe; Kay J Park; William T Creasman; Michael J Birrer; David Mutch; Kimberly K Leslie
Journal:  Gynecol Oncol       Date:  2017-09-29       Impact factor: 5.482

6.  Circ_0002577/miR-126-5p/MACC1 axis promotes endometrial carcinoma progression by regulation of proliferation, migration, invasion, and apoptosis of endometrial carcinoma cells.

Authors:  Wenzhi Wang; Wen Jin; Xiaoying Liu; Lei Zheng
Journal:  Arch Gynecol Obstet       Date:  2022-02-01       Impact factor: 2.493

7.  MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells.

Authors:  Jiping Wang; Li Zhang; Wenyan Jiang; Rongkui Zhang; Bei Zhang; Aidaeraili Silayiding; Xiumei Duan
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-11-15

8.  Long Noncoding RNA HOXB-AS1 Is Upregulated in Endometrial Carcinoma and Sponged miR-149-3p to Upregulate Wnt10b.

Authors:  Da Liu; Min Qiu; Lili Jiang; Kuiran Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.